Ending the U.S. government’s war on medical marijuana research
Of all the controlled substances that the federal government
regulates, cannabis is treated in unique ways that impede research.
Specifically, the U.S. government has held back the medical community's
ability to conduct the type of research that the scientific community
considers the experimental gold standard in guiding medical practice.
Thus, the use of cannabis for medical treatment is happening in states
based largely on anecdotal or limited science. In many cases, patients
and doctors operate according to a learn-as-you-go approach—a situation
that is inexcusably the fault of federal policies failing to keep pace
with changing societal views and state-level legal landscapes.
In “Ending the U.S. government's war on medical marijuana research,”
authors John Hudak and Grace Wallack argue that it is time for the
federal government to recognize the serious public policy risks born
from limited medical, public health, and pharmaceutical research into
cannabis and its use.
No comments:
Post a Comment